Drug & intervention

ganaxolone

RxCUI 2604689

Clinical trials4

Recruiting0

Related conditions3

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

4 shown

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related EpilepsyNCT05604170 · 2022-05-16

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related EpilepsyNCT05323734 · 2022-04-01

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)NCT04285346 · 2020-04-08

Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid AllopregnanoloneNCT02900092 · 2016-11-01

Conditions being studied

Tuberous Sclerosis Complex2 Major Depressive Disorder1 Tuberous Sclerosis1

Research locations

BostonMassachusetts, United States3 CincinnatiOhio, United States3 DurhamNorth Carolina, United States3 HoustonTexas, United States3 Los AngelesCalifornia, United States3 AuroraColorado, United States2 AustinTexas, United States2 BarcelonaSpain2 BeijingChina2 BonnGermany2 BristolUnited Kingdom2 BronFrance2

Leading sponsors

Marinus Pharmaceuticals3 Massachusetts General Hospital1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.